MASUI
BBIO icon

MIRAE ASSET SECURITIES (USA) INC.’s BridgeBio Pharma BBIO Stock Holding History

MIRAE ASSET SECURITIES (USA) INC.’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-51,818
Closed -$3.95M – 169
2025
Q4 		$3.95M Buy
+51,818
New +$3.4M 0.11% 132

Other funds holding BBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MIRAE ASSET SECURITIES (USA) INC.'s BBIO Position: Q1 2026 in Review

MIRAE ASSET SECURITIES (USA) INC. sold out of BridgeBio Pharma (BBIO) in Q1 2026, closing a stake of 51,818 shares — an estimated $3.96M sold.

MIRAE ASSET SECURITIES (USA) INC. first reported a position in BBIO in Q4 2025 and held it in 1 quarter. The position peaked at $3.96M in Q4 2025. 458 funds tracked by Wall St. Rank hold BBIO as of Q1 2026.

  • MIRAE ASSET SECURITIES (USA) INC. reported no remaining BridgeBio Pharma position as of Q1 2026 after selling out during the quarter.
  • MIRAE ASSET SECURITIES (USA) INC. sold 51,818 BridgeBio Pharma shares in Q1 2026, an estimated $3.96M.
  • MIRAE ASSET SECURITIES (USA) INC. first reported a position in BridgeBio Pharma in Q4 2025 and held it in 1 quarter.
  • MIRAE ASSET SECURITIES (USA) INC.'s BridgeBio Pharma position peaked at $3.96M in Q4 2025.
  • 458 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q1 2026.

Based on MIRAE ASSET SECURITIES (USA) INC.'s 13F filing for Q1 2026, filed 29 Apr 2026.